Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin‐converting enzyme inhibitors – a nationwide registry‐based cohort study

It has long been suggested that angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (AT2s) have some degree of ‘cross‐reactivity' in causing angioedema. Therefore, caution has been advised when switching patients with ACEi‐related angioedema to an AT2.

[1]  P. Schuler,et al.  Clinical features of angioedema induced by renin-angiotensin-aldosterone system inhibition: a retrospective analysis of 84 patients , 2019, Journal of community hospital internal medicine perspectives.

[2]  J. Auer,et al.  [Austrian Consensus on High Blood Pressure 2019]. , 2019, Wiener klinische Wochenschrift.

[3]  Vinesh Kumar,et al.  Demographic and Clinical Characteristics of Patients Presenting With Angiotensin-converting Enzyme Inhibitors Induced Cough , 2019, Cureus.

[4]  A. Maetzel,et al.  Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies , 2018, Orphanet Journal of Rare Diseases.

[5]  A. White,et al.  Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review. , 2017, Clinical therapeutics.

[6]  Jian Zhang,et al.  Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials , 2017, BMC Cardiovascular Disorders.

[7]  R. Ferreira,et al.  A rash decision. The hazards of the wrongful use of adrenaline. , 2017, Romanian journal of anaesthesia and intensive care.

[8]  C. von Buchwald,et al.  Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema , 2017, International journal of otolaryngology.

[9]  H. Sørensen,et al.  Data Resource Profile: The Danish National Prescription Registry , 2016, International journal of epidemiology.

[10]  Sigrun Alba Johannesdottir Schmidt,et al.  The Danish National Patient Registry: a review of content, data quality, and research potential , 2015, Clinical epidemiology.

[11]  F. Lapostolle,et al.  Angioedema Related to Angiotensin-Converting Enzyme Inhibitors , 2015, Medicine.

[12]  A. Soliman,et al.  Angiotensin Converting Enzyme Inhibitor-Related Angioedema , 2015, The Annals of otology, rhinology, and laryngology.

[13]  J. Sheikh,et al.  Angioedema deaths in the United States, 1979-2010. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  Henrik Toft Sørensen,et al.  The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.

[15]  Jesper Hallas,et al.  Assigning exposure duration to single prescriptions by use of the waiting time distribution , 2013, Pharmacoepidemiology and drug safety.

[16]  C. Sampaio,et al.  Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors , 2012, American Journal of Cardiovascular Drugs.

[17]  A. Linneberg,et al.  Epidemiology of non-hereditary angioedema. , 2012, Acta dermato-venereologica.

[18]  L. Thygesen,et al.  Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving , 2011, Scandinavian journal of public health.

[19]  J. Avorn,et al.  Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. , 2010, American journal of epidemiology.

[20]  Donald R. Miller,et al.  Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme Inhibitors , 2008, Hypertension.

[21]  J. Craig,et al.  Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. , 2006, The Cochrane database of systematic reviews.

[22]  B. Davis,et al.  Incidence and Predictors of Angioedema in Elderly Hypertensive Patients at High Risk for Cardiovascular Disease: A Report From the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2006, Journal of clinical hypertension.

[23]  R. Ferner,et al.  Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine , 2006, BMJ : British Medical Journal.

[24]  H. Sørensen,et al.  Risk of first-time hospitalization for angioedema among users of ACE inhibitors and angiotensin receptor antagonists. , 2005, The American journal of medicine.

[25]  T. Casale,et al.  Incidence and characteristics of angioedema associated with enalapril. , 2005, Archives of internal medicine.

[26]  E. Mannucci,et al.  Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus , 2005, Diabetologia.

[27]  R. Meyboom,et al.  Use of angiotensin receptor antagonists in patients with ACE inhibitor induced angioedema , 2004, Pharmacy World and Science.

[28]  M. Cicardi,et al.  Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. , 2004, Archives of internal medicine.

[29]  D. Vidt.  Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor? , 2001, Cleveland Clinic journal of medicine.

[30]  F. Messerli,et al.  Vasopeptidase inhibition and angio-oedema , 2000, The Lancet.

[31]  Kelly K Warner,et al.  Angiotensin II Receptor Blockers in Patients with ACE Inhibitor–Induced Angioedema , 2000, The Annals of pharmacotherapy.

[32]  M. Cicardi,et al.  Angioedema due to angiotensin-converting enzyme inhibitors. , 1999, Immunopharmacology.

[33]  L. Prisant,et al.  Losartan: First of a New Class of Angiotensin Antagonists for the Management of Hypertension , 1996, Journal of clinical pharmacology.

[34]  S. Yusuf,et al.  Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .

[35]  S. Yusuf,et al.  Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. , 1995, JAMA.

[36]  M. Dufour,et al.  Epidemiology. Introduction. , 1995, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.

[37]  M. Anderson,et al.  Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: the effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamine. , 1990, The Journal of allergy and clinical immunology.